|
II. Lymphadenopathies |
|
1. Reactive Lymphadenopathies |
|
|
▪ Reactive Lymphoid Hyperplasia |
|
|
▪ Atypical Lymphoid Hyperplasia |
|
|
▪
Progressive Transformation of Germinal Centers |
|
2. Lymphadenopathies Associated with Clinical
Syndromes |
|
|
▪ Kimura Lymphadenopathy |
|
|
▪ Kikuchi Lymphadenopathy |
|
|
▪ Systemic Lupus Lymphadenopathy |
|
|
▪ Dermatopathic Lymphadenopathy |
|
|
▪
Sinus Histiocytosis with Massive
Lymphadenopathy |
|
|
▪ Sarcoidosis Lymphadenopathy |
|
|
▪ Rheumatoid Lymphadenopathy |
|
|
▪ Castleman Lymphadenopathy |
|
|
▪
Tumor-Reactive Lymphadenopathy |
|
|
▪ Lymphadenopathies of Salivary
Glands |
|
3. Iatrogenic Lymphadenopathies |
|
|
▪ Drug-Induced Lymphadenopathy:
Methotrexate |
|
|
▪
Drug-induced Lymphadenopathy |
|
4. Vascular Lymphadenopathies |
|
|
▪ Lymph Node Infarction |
|
|
▪ Vascular Transformation of
Sinuses |
|
5. Foreign Body Lymphadenopathies |
|
|
▪ Proteinaceous Lymphadenopathy |
|
|
▪ Lipid Lymphadenopathy |
|
|
▪
Gold Lymphadenopathy |
|
|
▪ Silicone Lymphadenopathy |
|
|
▪
Tattoo Lymphadenopathy |
|
|
▪ Lymphadenopathy of Metal Debris
Associated with Joint Prostheses |
|
6. Lymph Node Inclusions |
|
|
▪ Epithelial Cell Inclusions in
Lymph Nodes |
|
|
▪
Nevus Cell Inclusions in Lymph Nodes |
